| Diane K Murphy, CRNA | |
|
2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116-3254 | |
| (816) 691-2021 | |
| (816) 346-7690 |
| Full Name | Diane K Murphy |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 2700 Clay Edwards Dr Ste 240, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497103048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 138915 (Missouri) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 2016020587 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Luke's East Hospital | Lees summit, MO | Hospital |
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes East Anesthesia Services,p.c. | 1850333477 | 40 |
| Meritas Health Corporation | 6305748153 | 365 |
| Digestive Health Specialists Llc | 9739494832 | 71 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Entity Name | Outpatient Anesthesia Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194828673 PECOS PAC ID: 8325930803 Enrollment ID: O20040329000795 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Entity Name | St Lukes East Anesthesia Services,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649283177 PECOS PAC ID: 1850333477 Enrollment ID: O20050524001050 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Entity Name | Digestive Health Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801286844 PECOS PAC ID: 9739494832 Enrollment ID: O20150819006984 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diane K Murphy, CRNA 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116-3254 Ph: (816) 691-2021 | Diane K Murphy, CRNA 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116-3254 Ph: (816) 691-2021 |
News Archive
Although scientists have speculated over the negative effects of environmental toxins for years, new data suggest that certain environmental toxins may disrupt the normal growth and hormonal development of girls.
BIOVISION, the annual life sciences forum organized by the Foundation for the University of Lyon, today announces its 10thedition, which will take place on April 15 and 16, 2015 at the Musée des Confluences in Lyon, France.
ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.
Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
› Verified 4 days ago
Mr. Todd J Zellmer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2800 Clay Edwards Drive, North Kansas City, MO 64116 Phone: 816-221-5050 Fax: 816-471-1247 | |
Ms. Jeanne M Cooper, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2800 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-691-2000 | |
Steven R Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2800 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-221-5050 Fax: 816-471-1247 | |
Mrs. Kimberly A. Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2800 Clay Edwards Dr, North Kansas City, MO 64116 Phone: 816-221-5050 Fax: 816-471-1247 | |
Jeffrey Bradford Enriquez Casperson, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116 Phone: 816-691-2021 Fax: 816-346-7690 | |
Aimee M Callison, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116 Phone: 816-691-2021 Fax: 816-346-7690 | |
Kathryn Elizabeth Morgan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116 Phone: 816-691-2021 |